Is There Evidence for Vasculitis in Systemic Sclerosis?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Rheumatology Reports

• Publication date

  2012-10-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11926-012-0296-9PMID 23065452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression

  2014cited by this paper
• IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

  2012cited by this paper
• Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection.

  2012cited by this paper
• Endothelin receptor antagonists for the treatment of pulmonary artery hypertension.

  2012cited by this paper
• Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis

  2012cited by this paper
• Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols

  2012cited by this paper
• Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers

  2012cited by this paper
• The influence of measurement location on reliability of quantitative nailfold videocapillaroscopy in patients with SSc.

  2012cited by this paper
• Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study.

  2012cited by this paper
• Anti-neutrophil antibody associated vasculitis in systemic sclerosis.

  2011cited by this paper
• Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.

  2011cited by this paper
• A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis.

  2011cited by this paper
• Induction of apoptosis in circulating angiogenic cells by microparticles.

  2011cited by this paper
• Genetics of Systemic Sclerosis: An Update

  2011cited by this paper
• CLINICAL SIGNIFICANCE OF DEFINED ANCA POSITIVITY IN SYSTEMIC SCLEROSIS

  2011cited by this paper
• The genetics of systemic sclerosis: an update.

  2011cited by this paper
• Overexpression of VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis

  2011cited by this paper
• Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis

  2011cited by this paper
• Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis

  2011cited by this paper
• Platelet-derived serotonin links vascular disease and tissue fibrosis

  2011cited by this paper
• Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

  2010cited by this paper
• Capillaroscopic pattern in systemic sclerosis - an association with dynamics of processes of angio- and vasculogenesis.

  2010cited by this paper
• EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

  2010cited by this paper
• Antiendothelial Cell Antibodies Induce Apoptosis of Bone Marrow Endothelial Progenitors in Systemic Sclerosis

  2010cited by this paper
• Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.

  2010cited by this paper
• The Plasminogen Activator System in Fibroblasts from Systemic Sclerosis

  2010cited by this paper
• Myopathies related to systemic sclerosis: a case–control study of associated clinical and immunological features

  2010cited by this paper
• Involvement of functional autoantibodies against vascular receptors in systemic sclerosis

  2010cited by this paper
• Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis.

  2009cited by this paper
• Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis

  2009cited by this paper
• A growing need for capillaroscopy in rheumatology.

  2009cited by this paper
• Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases.

  2009cited by this paper
• Transcription Factor Fos-Related Antigen-2 Induces Progressive Peripheral Vasculopathy in Mice Closely Resembling Human Systemic Sclerosis

  2009cited by this paper
• Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy

  2009cited by this paper
• EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

  2008cited by this paper
• Vascular disease in scleroderma: mechanisms of vascular injury.

  2008cited by this paper
• Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?

  2008cited by this paper
• Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity

  2008cited by this paper
• Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.

  2008cited by this paper
• Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

  2007cited by this paper
• Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis

  2007cited by this paper
• Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis.

  2007cited by this paper
• Changes in causes of death in systemic sclerosis, 1972–2002

  2007cited by this paper
• Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis

  2007cited by this paper
• Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases.

  2007cited by this paper
• The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.

  2006cited by this paper
• Bone marrow endothelial progenitors are defective in systemic sclerosis.

  2006cited by this paper
• Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.

  2006cited by this paper
• Radiological hand involvement in systemic sclerosis

  2006cited by this paper
• Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells.

  2006cited by this paper
• Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells.

  2006cited by this paper
• Abnormal microvascular response is localized to the digits in patients with systemic sclerosis.

  2006cited by this paper
• Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis.

  2006cited by this paper
• Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies.

  2006cited by this paper
• Platelet-derived Growth Factor and Reactive Oxygen Species (ROS) Regulate Ras Protein Levels in Primary Human Fibroblasts via ERK1/2

  2005cited by this paper
• Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis

  2004cited by this paper
• Defective vasculogenesis in systemic sclerosis.

  2004cited by this paper
• Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.

  2004cited by this paper
• The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study

  2004cited by this paper
• Hyperplasia of dermal microvascular pericytes in scleroderma *

  2004cited by this paper
• Pericyte‐specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation

  2003cited by this paper
• Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

  2003cited by this paper
• Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia.

  2003cited by this paper
• Microvascular Abnormalities in Chronic Heart Failure: A Cross‐Sectional Analysis

  2003cited by this paper
• Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.

  2002cited by this paper
• Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.

  2001cited by this paper
• Gastric involvement in systemic sclerosis: a prospective study

  2001cited by this paper
• Gastric involvement in systemic sclerosis: a prospective study.

  2001cited by this paper
• Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.

  2001cited by this paper
• Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality.

  1999cited by this paper
• Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis.

  1999cited by this paper
• Distribution of macrovascular disease in scleroderma

  1998cited by this paper
• Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment.

  1998cited by this paper
• Electron microscopy and capillaroscopically guided nailfold biopsy in connective tissue diseases: detection of ultrastructural changes of the microcirculatory vessels.

  1998cited by this paper
• Prevalence of Antineutrophil Cytoplasmic Antibodies in a Large Inception Cohort of Patients with Connective Tissue Disease

  1997cited by this paper
• Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.

  1996cited by this paper
• Retroviruses and the pathogenesis of systemic sclerosis.

  1995cited by this paper
• Antineutrophil cytoplasmic autoantibodies in systemic sclerosis with renal failure.

  1995cited by this paper
• Limited scleroderma is associated with increased prevalence of macrovascular disease.

  1995cited by this paper
• Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

  1969cited by this paper

• Exploring the Utility of Circulating Endothelial Cell-Derived Extracellular Vesicles as Markers of Health and Damage of Vasal Endothelium in Systemic Sclerosis Patients Treated with Iloprost

  2024cites this paper
• Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimic

  2023cites this paper
• Role of NLRP3 inflammasome in systemic sclerosis

  2022cites this paper
• A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

  2021cites this paper
• Endothelial‐to‐mesenchymal transition in systemic sclerosis

  2021cites this paper
• Modeling angiogenesis with micro- and nanotechnology.

  2017cites this paper
• Vasculopathy of the central nervous system in limited systemic sclerosis

  2016cites this paper
• The Scenario : Damage and Remodelling of the Microvasculature in Systemic Sclerosis

  2016cites this paper
• [Vasculopathy of the central nervous system in limited systemic sclerosis].

  2016cites this paper
• Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study

  2015cites this paper
• Sistemik skleroz hastalar›nda mevcut kapilleroskopik bulgular ve hastal›k tutulumlar› aras› iliflkinin deerlendirilmesi Evaluation of association between capillaroscopic findings and organ involvements in Turkish systemic sclerosis patients

  2015cites this paper
• Choroidal Changes in Patients with Raynaud's Phenomenon Secondary to a Connective Tissue Disease: Study of Vascular Eye Involvement in Patients Affected by Raynaud's Phenomenon with in vivo Noninvasive EDI-OCT

  2014cites this paper
• Evaluation of association between capillaroscopic findings and organ involvements in Turkish systemic sclerosis patients

  2014cites this paper
• The Primary Care Physician in the Early Diagnosis of Systemic Sclerosis: The Cornerstone of Recognition and Hope

  2014cites this paper
• Oxidative Stress Elicits Platelet/Leukocyte Inflammatory Interactions via HMGB1: A Candidate for Microvessel Injury in Sytemic Sclerosis

  2014cites this paper